Last reviewed · How we verify
NCT07274176
The Effect of Graded Forced Expiration on Intraocular Pressure
NA trial testing Intraocular Pressure after forced expiration in Intraocular Pressure in 60 participants. Currently enrolling.
10 February 2026
Quick facts
| Lead sponsor | Uşak University |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | screening |
| Enrollment | 60 |
| Start date | 15 December 2025 |
| Primary completion | 10 February 2026 |
| Estimated completion | 25 February 2026 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Intraocular Pressure after forced expiration
Conditions studied
- Intraocular Pressure — all drugs for Intraocular Pressure →
Sponsor
Uşak University
Who can join
Adults 18 to 65, any sex, with Intraocular Pressure. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The primary objective of this study is to utilize the Airofit device to systematically measure and characterize the changes in intraocular pressure across its six different levels of forced expiration. This investigation will provide crucial quantitative data on the IOP-respiratory effort relationship, enhancing our understanding of IOP dynamics during controlled respiratory stress and establishing a new, standardized paradigm for such research.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07274176
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Intraocular Pressure
Currently open trials in the same condition.
- NCT06666751 — Anterior Segment Optical Coherence Tomography Microstent Positioning · active not recruiting
- NCT06016712 — The Effect of Labor on Intraocular Pressure Fluctuation in Healthy Eyes · NA · recruiting
- NCT05753137 — Acupuncture as Adjuvant Therapy for Glaucoma - Protocol for a Randomized Controlled Trial · NA · recruiting
- NCT05850936 — Effect of IOP Lowering on Progressive HM · NA · active not recruiting
- NCT06275308 — Effect of Raised End-Tidal pCo2 on Choroidal Volume · NA · recruiting
Other Uşak University trials
Trials by the same sponsor.
- NCT07356362 — High-power Laser Therapy for Notalgia Paresthetica. · NA · not yet recruiting
- NCT07328360 — The Efficacy of High-Power Laser Therapy in Meralgia Paresthetica · NA · recruiting
- NCT07276477 — Inspiratory Muscle Training After Stroke · NA · recruiting
- NCT07296380 — Manual Therapy Behavior Scale in Physiotherapists · enrolling by invitation
- NCT07296367 — Physiotherapy and Disaster · enrolling by invitation
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07274176 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Uşak University
- Last refreshed: 22 December 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07274176.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing